It has been established that Brucella organisms localize intracellularly within the tissues of animals and human beings (1) (2) (3) (4) (5) (6) . As pointed out elsewhere (7, 8) , the majority of patients with brucellosis recover from their illness within a year. While there is no doubt that the duration of the illness in the majority of patients is considerably shortened by the administration of antibiotics, there still remains a small but significant number of patients who continue to have manifestations of active infection after what is considered to be adequate therapy (9) . There is evidence that the chronicity of the disease may be due to the continued parasitization of the tissue cells by brucella organisms. Although effective therapeutic agents are available for brucellosis, in vitro investigations have demonstrated that Brucella organisms located in the cytoplasm of the cells of the host are protected against the action of the antibiotics, and also against the antibacterial action of serum (10, 11) .
In tuberculosis, the invading bacilli tend to localize within the cells of the host, and, possibly multiply there (12) . Furthermore, it has been demonstrated in tissue cultures that the extracellular organisms of Mycobacterium tuberculosis are readily destroyed by streptomycin, but those bacilli within the macrophages are protected against the lethal action of the drug (13) . Hart and Rees (14) have reported that tubercle bacilli are widely disseminated in mice with acute and chronic tuberculosis following the administration of cortisone. Apparently, the dissemination of tubercle 1 Reviewed by the Veterans Administration and published with the approval of the Chief Medical Director. The statements and conclusions published by the authors are the result of their own study and do not necessarily reflect the opinion or policy of the Veterans Administration.
bacilli from localized areas as a result of treatment with cortisone is not controlled by an extracellular immune mechanism, since the organisms multiply and invade other cells. Abernathy and Spink (15) observed that the administration of cortisone in mice having acute brucellosis results in the dissemination and multiplication of Brucella organisms, and a fulminating and fatal infection ensues. However, in the chronically infected animal, cortisone was without demonstrable effect, probably due in part to an efficient immune mechanism that prevented multiplication of the bacteria and invasion of other cells of the host.
Although experimental and clinical observations have demonstrated quite clearly that the continued illness of both animals and human subjects can be due to the persistence of Brucella organisms in the tissues, it has been difficult to demonstrate the intracellular localization of the Brucella. An analogous situation occurs in rickettsial diseases. It is an accepted fact that the rickettsiae invade the host's tissue cells, but demonstration of the intracellular position of the parasites in human material is often accomplished only after extensive search. Accepting the thesis that Brucella organisms localize and persist intracellularly, ACTH was administered to a group of patients having an acute or chronic illness due to Brucella in the anticipation that the organisms would be released from their intracellular location. It :-an increase in the total leukocyte count and a diminution in the number of lymphocytes and eosinophile cells.
Case 2. W. J. K., a 34-year-old white tenant farmer had the onset of an illness eight weeks prior to entering the hospital. The initial manifestations were chills and a fever of 104°F. He took aureomycin for a brief period of time, and he became afebrile; but he continued to feel weak and he had a relapse of chills and fever. He then received aureomycin and penicillin, and concomitantly his temperature became normal, but after several days there was a recurrence of daily chills and fever. Until he presented himself for his final hospital admission in Minneapolis the diagnosis of brucellosis had not been established. He worked with a large herd of high-grade dairy cattle, and although there had not been any abortions in the herd for three years, he had assisted the local veterinarian in vaccinating the calves twice yearly with a viable culture of strain 19 Br. abortus.
The herd had not been tested recently for Bang's disease.
He appeared quite toxic with a temperature of 101.4°F. There were no abnormal physical findings other than the edge of a tender liver 4 cms. below the costal margin. Jaundice was not present. Prior to the administration of ACTH the total leukocyte count was 5 not know of any Bang's disease in his herd of cattle, but his neighbor's cattle in an adjoining pasture had the disease. His temperature was 104°F., and he had lymphadenopathy, hepatomegaly, and an enlarged and tender spleen. The titer of Brucella agglutinins was 1 to 1,280, and Br. abortus organisms were isolated from the blood on two occasions. He was given aureomycin, and then terramycin, after which his symptoms subsided. The spleen was still palpable at the costal margin. Three cultures of blood taken on consecutive days remained sterile, and the titer of agglutinins was 1 to 1,280. A month later he was still without symptoms and afebrile, but the spleen was just palpable. Brucella agglutinins were present in a titer of 1 to 320, and a blood culture remained sterile. Six months later he complained of weakness. He was afebrile, and the spleen could not be felt. Two blood cultures remained sterile, and the titer of agglutinins was 1 to 160.
He was readmitted to the hospital nine months after his initial hospitalization because he tired easily. He admitted using alcohol excessively. He was afebrile. The spleen was not palpable. The total leukocyte count was 7,000 with 72 per cent neutrophiles and 19 per cent lymphocytes. The erythrocyte sedimentation rate was normal. An agglutination test showed incomplete clumping of the brucella antigen up to a titer of 1 to 160. Two other agglutination tests revealed no agglutinins in his serum. Daily cultures of blood for three days remained sterile. He was given 20 mg. of ACTH subcutaneously four times daily for one week. During this time the patient felt stronger, but there were no objective changes noted. There were no alterations of the leukocyte counts or of the sedimentation rate. On the sixth day of therapy with ACTH there was no immediate skin reaction following the intradermal injection of 0.1 ml. of a 1 to 100 dilution of Brucella carbohydrate, and 24 hours later only a moderate reaction was seen. A skin test with heat-killed Brucella cells also showed a moderate reaction of the delayed type. After 15 days of hospitalization he was discharged. He felt well. When examined three months later he still felt well. At this time the antigen was only partially agglutinated by his serum in a titer of 1 to 160, and two blood cultures remained sterile. He has continued in good health for a year.
Comment: This was the first patient with presumed chronic brucellosis who was treated with ACTH. Although there is no doubt that he had acute brucellosis, there is some question as to whether a chronic infection was responsible for his ill health at a later time. He felt weak, but he was an alcoholic. He had a declining titer of Brucella agglutinins, and the test showed incomplete clumping of the antigen, which is so characteristic of the serum of those patients who have recovered from brucellosis. It is of interest that ACTH diminished but did not abolish the delayed type of dermal hypersensitivity to Brucella antigens. given intramuscularly twice daily. Treatment was discontinued because of the appearance of weakness, anorexia, and a display of hostility. An elevation of eosinophile cells to 12 per cent occurred. His behavior was thought to be an unusual type of reaction to the treatment, because as soon as the drugs were withheld the symptoms abated and the eosinophilia disappeared. His Brucella agglutinins showed a titer of 1 to 320, and nine cultures of blood remained sterile during and after treatment. He remained afebrile up to three months later. The titer of agglutinins was 1 to 80, and a blood culture was sterile.
Comment: This represented an unusual case of chronic brucellosis in our experience, since the patient had been ill for two years without any localizing manifestations and at the end of this time Br. aborts was cultured from his blood. He appeared to improve following treatment with aureomycin. His blood cultures remained sterile, although many specimens. were studied. It was concluded that he still had active disease just prior to his receiving ACTH. Temporary improvement occurred while ACTH was being administered but the manifestations of an active disease appeared shortly thereafter. He apparently responded satisfactorily to treatment with aureomycin and dihydrostreptomycin.
Case 6. A. J., a 35-year-old white electrician employed in a meat packing plant first became ill with joint pains, nocturnal sweats, chills, cold feet, and fatigue. After two months of continued illness he was sent to a hospital for pulmonary tuberculosis because an X-ray film of the chest revealed a diffuse infiltration. Extensive studies eliminated tuberculosis. Although only a low-grade fever was present, Br. abortus was isolated from blood cultures on two occasions. He was given 2 gm. of chloramphenicol daily for 10 days and felt better. It was concluded that the pulmonary changes were unrelated to his brucellosis. A film of the chest taken some time before the onset of his illness had revealed lesions in the lungs. It was brought out on questioning that as an electrician he had broken fluorescent light tubes on many occasions, and berrylium intoxication was considered but never proven as the cause of the findings in the lung. He continued well until seven months after his discharge from the hospital when he suffered from pain in the chest, sweats, nervousness, backache and fatigue. Although blood cultures remained sterile, Brucella agglutinins were present in a titer of 1 to 640. He was given 0.5 gm. of aureomycin four times daily for two weeks after which he felt improved.
Four months later, or 16 months after the onset of his illness, he presented himself again because of nervousness, weakness, and sweats. It was decided to administer ACTH. He was afebrile and no abnormal physical findings could be detected. The leukocyte count was 6,850 with 81 per cent neutrophiles and 16 per cent lymphocytes. The sedimentation rate was normal. The titer of brucella agglutinins was 1 to 640 and a culture of blood remained sterile. He was given 20 mg. of ACTH subcutaneously every six hours for 10 days. A remarkable change took place in this patient within 24 hours. His mental depression subsided and his appetite increased considerably. The patient stated that he felt better than he had for many months. On the fifth day an intradermal test with brucellergen revealed a very slight reaction in 24 hours. The agglutinin titer was 1 to 1,280, and seven cultures of blood during and after the administration of ACTH remained sterile. Fifteen hours after the injections of ACTH had been discontinued the patient experienced excrutiating pains in both knees with radiation to a point between the knees and ankles. Morphine was necessary to allay the pain. There was no redness or swelling of the extremities. Within four days the pain had completely subsided. The patient went back to work and was well until nine months later when he had a spontaneous pneumothorax. After a brief period of hospitalization the lung re-expanded. At this time his Brucella agglutinins were 1 to 640, and blood cultures were sterile. He returned to work. Comment: Of all the patients with chronic brucellosis who received ACTH this patient experi-enced the greatest benefit. His illness was complicated by a diffuse pulmonary infiltration of doubtful etiology, which was probably unrelated to his brucellosis, and not benefitted by ACTH.
Case 7. H. J., a 51-year-old white farmer nine months prior to being studied had had a sore throat, pain in both shoulders, and bilateral orchitis. He had been treated with an antibiotic which was followed by partial relief of his symptoms. Two months later he had a "kidney infection" and then he developed a severe pain in his right shoulder. Subsequently the pain extended down the arm and involved the right hand so that his fingers became stiffened and movement was painful. He was incapacitated from working as a farmer. He had a herd of 31 cattle in which abortions had occurred, but no tests for Bang's disease had been made. He was afebrile. There was muscular atrophy in the region of the right shoulder, and pressure over the acromial area elicited pain. The fingers of the right hand were swollen and flexion was impaired. The right arm could not be elevated above the level of the shoulder. The white blood count was 7,700 with 64 per cent neutrophiles and 24 per cent lymphocytes. The sedimentation rate was normal. The brucella agglutinin titer was 1 to 160, and blood cultures remained sterile. An X-ray film of the right shoulder revealed marked decalcification of the right humerus, especially the head. In addition, there was decalcification of the glenoid process and evidence of destruction along one margin of the rim of the glenoid.
He was treated simultaneously with dihydrostreptomycin, aureomycin and ACTH. He was given 0.5 gm. of dihydrostreptomycin intramuscularly twice daily and 0.5 gm. of aureomycin orally every six hours for two weeks. At the same time he received 32.5 mg. of ACTH intramuscularly every six hours for two weeks. Therapy with aureomycin alone was continued another week. Physiotherapeutic measures for the right arm were also instituted. Under this regimen there was gradual improvement. There was no change in his agglutinin titer and a blood culture remained sterile. When seen two months after the completion of his treatment, he was back at work. There had been continued improvement, but there still was some limitation in movement of the right arm.
Comment: This patient was considered to have had a severe attack of acute brucellosis nine months prior to receiving treatment with ACTH. The severity of his illness 'was evidenced by the presence of bilateral orchitis and a destructive lesion of the joint of the right shoulder. He had received antibiotic therapy in amounts sufficient to control the infection partially, but not enough to prevent the appearance of an unusual manifestation of brucellosis, that of a shoulder-hand. syndrome. Because of the destructive lesion of a joint it was deemed inadvisable to administer ACTH without affording the patient protection with an antibacterial agent or agents. ACTH appeared to be desirable therapeutically in view of the stiffened fingers of the right hand. For these reasons, antibacterial drugs and ACTH were administered simultaneously, and coincident with this therapeutic approach there was definite improvement in the condition of the patient. His health was restored enough to permit him to resume work.
DISCUSSION
The most striking effects of ACTH in human brucellosis were elicited in those patients who had had symptoms for less than three months (Cases 1 and 2). Both of these patients had a demonstrable bacteremia due to Br. abortus just prior to the administration of ACTH. The hormone did not have any deleterious effect on the clinical course of either patient; While no abrupt change was noted in Case 1, the patient did improve and there was no further evidence of bacteremia after the injections of ACTH were instituted. This patient did not suffer from any ill effects after the injections were discontinued, and he has remained well for 12 months. The sequence of events occurring in Case 2 as a result of ACTH may shed further light on the basic mechanisms of disease in brucellosis. In the first place, a febrile patient having a very toxic appearance was converted into an afebrile individual having the appearance and feeling of decided improvement within 24 hours after the initial injection of ACTH. Although therapy with the antibiotics will provoke such improvement, the changes have not been so abrupt nor have they occurred so quickly (9) . This immediate improvement manifested itself in Case 2 although Br. abortus could readily be cultured from the blood. Similar responses have been observed in patients with pneumococcic infections and those with typhoid fever treated with ACTH or cortisone (16) (17) (18) Another provocative series of observations made in Case 2 related to the tissue reactions induced by Brucella and the influence of ACTH upon these reactions. It is to be recalled that in Case 2, prior to the administration of ACTH, the liver was enlarged and tender, and the results of liver function studies were abnormal. In addition, a specimen of liver showed the presence of hepatitis, which is a common finding in human brucellosis (19) . Likewise, aspirated sternal bone marrow showed the characteristic granulomatous type of inflammation (20) . It was anticipated that the administration of ACTH might intensify these inflammatory reactions, but on the contrary, the tenderness and enlargement of the liver decreased shortly after the injections were begun, and specimens of liver and bone marrow examined after the completion of the injections of ACTH did not reveal any essential change. During the course of ACTH administration there were no alterations in the functional studies of the liver as compared to the studies carried out just before the start of ACTH administration.
The abrupt clinical improvement manifested by Case 2 without eradication of the bacteremia and without any change in the inflammatory reaction of the tissue suggested that ACTH inhibited the toxic action of a product or products ( ? endotoxin) of Brucella upon the body. It has been observed in this laboratory that the simultaneous administration of cortisone will protect mice against the lethal effect of Brucella endotoxin (21) .
The observations on experimental brucellosis in animals, especially in mice, which preceded these in human brucellosis, revealed that if animals were pretreated with cortisone and then infected with Brucella organisms, a fulminating and lethal infection ensued (15) . Specimens of the liver showed necrosis of the hepatic cells and tremendous numbers of Brucella organisms invading the parenchymal cells and engorging the macrophages in the liver sinusoids. In the control animals that had not received cortisone, the infection was relatively mild, the inflammatory reaction was of the granulomatous type with little or no necrosis, and proliferation of the bacterial cells not marked. No such a sequence of events was observed in the human cases of acute brucellosis treated with ACTH. Perhaps the essential difference is not that the animals received cortisone and the humans ACTH, but rather that cortisone was offered to the infected animals before any immune response to the infection had been established, whereas the human patients had been ill for a period of time sufficient to permit the development of an effective antibacterial mechanism. While much remains to be learned about tissue and humoral immunity in brucellosis, the observations in the chronically infected animals and human beings indicate that the immune mechanism is efficient enough to prevent a dissemination of the infection when cortisone or ACTH is administered. This is contrary to observations made in experimental and human tuberculosis (14, 22, 23 Upon the basis of the present observations, and because therapy with the antibiotics is so effective in the majority of patients, there is little or no indication for using either cortisone or ACTH in the treatment of human brucellosis. A further contraindication is the undesirable side effects induced by these agents. The one possible indication for the use of either cortisone or ACTH would be in a seriously ill and toxic patient. Even in such a case, treatment probably should be carried out only for a day or two, and simultaneous treatment should be started with streptomycin or dihydrostreptomycin, in combination with aureomycin or terramycin. A similar approach has been made in the treatment of typhoid fever (16, 17) .
The present results with ACTH in acute brucellosis have stimulated a further consideration of the mechanism whereby patients appear to benefit following the intravenous injection of Brucella antigens. Such authorities as Janbon (24) in Montpellier, France; Signorelli (25) in Farrar, Italy; and Huddleson (26) in this country have called attention to the beneficial results that have occurred in patients with acute and chronic brucellosis following the intravenous injection of Brucella antigens. It is of interest that improvement in the patient's condition is usually associated with a febrile reaction and, at times, a shocklike picture with a drop in blood pressure. Although it is often asserted that the Brucella preparations are specific in their beneficial action, some doubt has been cast upon this conclusion by the observations of Loffler and his associates (27) , who obtained equally good results following the injection of suspensions of colloidal silver. It might be postulated that the febrile reaction induced by these agents provoked a stress reaction which in turn stimulated the adrenals to produce corticosteroids with the results as presented in Cases 1 and 2. Another possibility is that the febrile reaction with its mild shock-like manifestations might be representative of a generalized Shwartzman reaction in which Brucella organisms are liberated from localized foci, and disposed of by an extracellular immune mechanism. Further studies along these lines are in progress at the present time. SUMMARY 1. Adrenocorticotrophic hormone (ACTH) was administered to two patients with acute brucellosis and, to five patients with chronic disease. The administration of ACTH to one of the patients with acute brucellosis, who was quite ill, was accompanied by a prompt and remarkable improvement although the blood cultures remained positive for Br. abortus. ACTH did not appear to have any significant effect on the clinical course of chronic brucellosis.
2. Specimens of liver and sternal bone marrow from one patient with acute brucellosis displaying granulomas showed no essential change in the type or degree of inflammation before and after the administration of ACTH.
3. ACTH had no significant effect upon the titer of Brucella agglutinins, but it did suppress dermal hypersensitivity to Brucella antigens. The tendency of Brucella organisms to cause a leukopenia and relative lymphocytosis was abolished by ACTH.
4. The only therapeutic indication for cortisone or ACTH at the present time in acute or chronic brucellosis is in patients who are quite ill and toxic. And even then, treatment should be carried out for only a few days and simultaneously with antibiotic therapy.
